A*STAR Bioprocessing Technology Institute (A*STAR BTI)

Examining the intermediate stages of antibody purification provides
insight into the manufacture of safer biopharmaceuticals at lower cost

To produce
mesenchymal stem cells in large numbers will require careful tuning of their
growth media

A tool for isolating progenitor cells from human heart tissue could pave the way for cardiac cell therapy

A standard purification process changes the structure of antibodies — and then changes them back

Self-cleaving peptides are key for easy and efficient monoclonal antibody production

The immune system relies on an enzyme called Bruton’s tyrosine kinase to sense nucleic acids from pathogens

Researchers at A*STAR are mass-producing stem cells to satisfy the demands of regenerative medicine

Insight into a molecular mechanism for regulating blood sugar could enhance our understanding of diabetes

Learning how a key protein affects programmed cell death could help to develop vaccines and drugs

Shp1 protein helps immune system develop its long-term memory

A scalable platform for growing heart muscle cells may lead to repair of damaged heart cells

Web tool offers COOL approach to codon optimization for synthetic biology